-
effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_2012-12-11.pdf
January 01, 2012 - data and postmarket safety evaluation—set
forth by the U.S. … Kushner and colleagues announced results from a phase III clinical trial (SEQUEL)
evaluating the safety … However, a
potential increase in per-patient cost might serve as a barrier to acceptance by some patients … While
preliminary results are promising, further studies evaluating efficacy and safety are needed, … Safety and efficacy study of
EndoBarrier in subjects with type II diabetes and
obesity.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-web-interactive-presentation.pdf
September 01, 2019 - Associate Chief Medical Officer for Patient Safety and Clinical Quality
Assistant Professor of Medicine … with urinary incontinence, as
well as health system decisions related to improving patient safety and … We engaged the Associate Chief Medical Officer (CMO)
for Patient Safety and Clinical Quality and the … The Associate Chief CMO for Patient Safety and Clinical Quality is tasked with setting
Duke’s quality … agenda and coordinating patient safety and clinical quality activities across the
Duke Health System
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-evidence-summary.pdf
August 01, 2018 - Future research should
also enroll people with different patient characteristics and
initial episodes … Are bipolar II patients
cognitively impaired? A systematic review. … Efficacy and safety of
olanzapine in the treatment of Japanese patients with bipolar
I disorder in … A randomized, double-
blind, placebo-controlled efficacy and safety study of quetiapine
or lithium as … Treatment in
a specialised out-patient mood disorder clinic v. standard
out-patient treatment in the
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_disposition-comments.pdf
January 01, 2015 - We removed the word safety from
the title for Table D. … We
have discussed patient preference as well as
cost briefly as potential drivers. … Efficacy and
safety of the once-weekly GLP-1 receptor agonist
albiglutide versus sitagliptin in patients … varies with patient
characteristics. … 16 patients 0.2 in the placebo group P 0.42
definite acute pancreatitis in 17 patients 0.2 and 9
patients
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/vaccine-safety_research-protocol.pdf
September 18, 2012 - System
(VAERS),11 the Vaccine Safety Datalink,12 and the Clinical Immunization Safety Assessment
Network … Both
patient factors (i.e., age and race) and vaccine factors (i.e., formulation, dosage, and timing … AEs) or passive (participants are not specifically asked about or tested for the
occurrence of AEs; patient … Multiple publications are defined by the investigated patients.
F. … The Vaccine Safety Datalink: a model for monitoring
immunization safety.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
May 01, 2022 - The pharmacokinetics, efficacy, and safety
of a novel selective-dose cannabis inhaler in
patients with … Pharmacokinetics, Safety, and Tolerability
of a Medicinal Cannabis Formulation in
Patients with Chronic … Efficacy, tolerability
and safety of cannabinoids for management
of pain in adult patients with multiple … Marijuana, Lower Urinary Tract Symptoms,
and Pain in the Urologic Patient. … Care of the Patient
Using Cannabis.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
January 01, 2015 - 7% by week 39.
9
The safety and efficacy of the ITCA 650 pump system compared with twice-daily … Summary of safety and effectiveness data
(SSED). MiniMed 530G system. P120010. … Important safety information: Animas Vibe
insulin pump and CCGM system. [internet]. … Available:
http://www.animas.com/safety.
27. … A study of the safety and efficacy of a
new treatment for diabetic macular edema.
-
effectivehealthcare.ahrq.gov/sites/default/files/methods-report-web-interactive-presentation-appendix-a.pdf
May 29, 2025 - Bae, MD: Associate Chief Medical Officer for Patient Safety and
Clinical Quality
• G.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_research-protocol.pdf
August 23, 2010 - What are the potential safety issues and harms associated with the use of non-invasive
diagnostic techniques … Guiding question 3:
What published and unpublished studies have reported on the use and safety of these … Provide a synthesis of the following information:
i Indication/patient inclusion criteria
ii Type … of techniques/modalities
iii Study design and size
iv Role of the test in patient management
v … Strategies for early melanoma detection: Approaches to the
patient with nevi.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
January 01, 2016 - Patients and their diabetes care
team work to adjust patient insulin dosages using feedback from a … complications would lower long-term, per-patient costs for both patients and third-
party payers. … Genentech has a patient-assistance program to help defray costs for qualified patients.175
Several … affecting patient acceptance. … Efficacy,
safety, and tolerability of exenatide once weekly
in patients with type 2 diabetes mellitus
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
January 01, 2016 - But the experts called for
longer safety and efficacy studies to determine whether this system would … Genentech has a patient assistance program to help defray costs for
qualified patients.135
Several … Efficacy and safety of exenatide once weekly
versus sitagliptin or pioglitazone as an adjunct to … Efficacy and safety of exenatide once weekly
versus metformin, pioglitazone, and sitagliptin
used … Efficacy,
safety, and tolerability of exenatide once weekly
in patients with type 2 diabetes mellitus
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritization-selection-of-harms.pdf
February 01, 2018 - http://www.fda.gov/Safety/MedWatch/HowToReport/ucm053087.htm
http://www.fda.gov/Safety/MedWatch/HowToReport … 9) How should input from technical and clinical experts and patients or patient advocacy groups be
used … How should input from technical and clinical experts and patients or patient advocacy groups be
used … Had to report data from
groups of in which at least
85% of the patients were
from one of the patient … What are the
harms of therapeutic interventions
for patients with ME/CFS and how
do they vary by patient
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment_research-protocol.pdf
September 29, 2011 - What are the significant safety concerns associated with each treatment strategy (i.e., adverse
drug … What are the significant safety concerns associated with each treatment strategy (i.e., adverse
drug … What are the significant safety concerns associated with each treatment strategy (i.e., adverse
drug … volume, setting, guideline-based
treatment protocols)
Safety and adverse effects, including … The safety outcomes will be framed to help
identify adverse events, including adverse drug reactions
-
effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_june_2012.pdf
January 01, 2012 - On the other
hand, some thought that knowing that a patient has AD could aid planning in terms of safety … and care of the patient … and care of the patient. … A diagnosis could, however, aid patients and families in planning for the patient’s care and safety. … AD
patients.
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
April 17, 2012 - data and postmarket safety
evaluation, set forth by the U.S. … FDA expressed concerns about the long-term cardiovascular safety profile in the overweight
and obese … Experts also opined that
further studies evaluating efficacy and safety are needed. … quality of life, thus impacting patient health outcomes. … Safety and efficacy study of
EndoBarrier in subjects with type II diabetes and
obesity.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-navigation-model-lung-cancer-rapid.pdf
December 01, 2018 - Eight categories of navigation activities
provided in studies including:
• Screening education
• Client … transport
• Ongoing barriers counseling
• Teaching test instructions
Minority FQHC clients
6 … review, electronic
client database, or
referral by provider.
7
Study Information
Author … among a racially diverse,
medically underserved population served by a safety-net health system. … Patient navigation for lung cancer screening
in an urban safety-net system: Protocol for a
pragmatic
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/psychiatric-readmissions_research-protocol.pdf
December 31, 2014 - demographics, diagnosis, and coexisting conditions; and
specific harms or safety issues? … demographics, diagnosis, and coexisting conditions; and specific
harms or safety issues? … demographics, diagnosis, and coexisting
conditions; and specific harms or safety issues? … Search terms
Search Query Items
found
#1 Search ("Patient Admission"[Mesh] OR "Patient Discharge" … "[All
Fields] OR "Patient Readmission"[Mesh] OR "brief admission"[All Fields] OR "patient
admission
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_research-protocol.pdf
January 01, 2020 - When should patient outcomes be measured (length of followup)? … Questions for Clinicians, Patients, and Patient Advocates.
a. … vibration (effectiveness, safety, FDA approval,
doctor recommendation, other)? … Upper gastrointestinal tract safety of
risedronate: a pooled analysis of 9 clinical trials. … Population
Country of residence of patients
Inclusion criteria
Exclusion criteria
Number of patients
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
January 01, 2007 - For adult patients with essential hypertension, how do ACEIs
and ARBs differ in safety, adverse events … For adult patients with essential hypertension, how do ACEIs and ARBs differ
in safety,d adverse events … For adult patients
with essential hypertension, how do
ACEIs and ARBs differ in safety,
adverse events … For adult patients with essential hypertension, how do ACEIs and ARBs differ
in safety,d adverse events … Many of the studies
reported limited data on patient characteristics, and black patients appeared to
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_8-user-guide-to-ocer_130129.pdf
October 01, 2013 - ablation for
hepatocellular carcinoma compared to resection
or no treatment5 and a comparison of the safety … missing biochemistry lab data
compared to early-stage patients (6-9% incomplete in early-stage patients … linked to Medicare claims, are a valuable resource
that has generated comparative effectiveness and
safety … Comparative assessment of the safety and
effectiveness of radiofrequency ablation
among elderly Medicare … Study
design for a comprehensive assessment of
biologic safety using multiple healthcare data
systems